 |
 |

Angiotensin-Converting Enzyme Insertion/Deletion Gene Polymorphic Variant as a Marker of Coronary Artery DiseaseA Meta-analysis
Elias Zintzaras, MSc, PhD;
Gowri Raman, MD;
Georgios Kitsios, MD;
Joseph Lau, MD
Arch Intern Med. 2008;168(10):1077-1089.
Background Many studies have investigated the association between the angiotensin-converting enzyme (ACE) gene insertion (I)/deletion (D) polymorphic variant and coronary artery disease (CAD). However, the evidence is inadequate to draw robust conclusions because most studies were generally small and conducted in heterogeneous samples. To shed light on these inconclusive findings, we conducted a meta-analysis of studies relating the ACE I/D polymorphic variant to the risk of CAD.
Methods We searched the PubMed database for English-language articles on CAD in humans. We estimated summary odds ratios and explored potential sources of heterogeneity and bias.
Results The 118 studies chosen for the analysis involved 43 733 cases with CAD and 82 606 controls. The heterogeneity between studies was significant. When we compared homozygotes with the D and I alterations, the ACE I/D polymorphic variant was associated with a 25% increased risk of CAD (odds ratio, 1.25; 95% confidence interval, 1.16-1.35). Subgroup analyses for myocardial infarction, diabetes mellitus, male sex, white race, East Asian subjects, and Turkish subjects showed significant associations. No association was found in other racial/ethnic groups, in women, in premature cases, or in cases with low levels of risk factors. The major sources of heterogeneity were due to racial/ethnic diversity, genotyping procedure, and age matching. Cumulative meta-analysis for the allelic contrast showed a trend of association as information accumulated. There was a differential magnitude of effect in large vs small studies.
Conclusions The meta-analysis demonstrated evidence of a modest positive association between ACE I/D polymorphic variant and CAD. The meta-analysis also highlights the heterogeneity of reported results, considerable gaps in research, and the need for future studies focused on certain high-risk patient populations.
Author Affiliations: Center for Clinical Evidence Synthesis, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts (Drs Zintzaras, Raman, and Lau); and Department of Biomathematics, University of Thessaly School of Medicine, Larissa, Greece (Drs Zintzaras and Kitsios).
CiteULike Connotea Delicious Digg Facebook Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Association of angiotensin converting enzyme insertion/deletion gene polymorphism with idiopathic nephrotic syndrome susceptibility in children: a meta-analysis
Zhou et al.
Journal of Renin-Angiotensin-Aldosterone System 2011;12:601-610.
ABSTRACT
Is the ACE I/D polymorphism associated with extreme longevity? A study on a Spanish cohort
Fiuza-Luces et al.
Journal of Renin-Angiotensin-Aldosterone System 2011;12:202-207.
ABSTRACT
Association between angiotensin-converting enzyme insertion/deletion gene polymorphism and atrial fibrillation: a meta-analysis
Liu et al.
Europace 2011;13:346-354.
ABSTRACT
| FULL TEXT
Meta-Analysis of Association Between Insertion/Deletion Polymorphism of the Angiotensin I-Converting Enzyme Gene and Venous Thromboembolism
Hsiao and Hsu
CLIN APPL THROMB HEMOST 2011;17:51-57.
ABSTRACT
Heterogeneity of the Phenotypic Definition of Coronary Artery Disease and Its Impact on Genetic Association Studies
Kitsios et al.
Circ Cardiovasc Genet 2011;4:58-67.
ABSTRACT
| FULL TEXT
The Influence of Gene Polymorphisms on Coronary Artery Disease
Kolovou and Giannakopoulou
ANGIOLOGY 2011;62:5-6.
Genetically determined angiotensin converting enzyme level and myocardial tolerance to ischemia
Messadi et al.
FASEB J. 2010;24:4691-4700.
ABSTRACT
| FULL TEXT
Are elite endurance athletes genetically predisposed to lower disease risk?
Gomez-Gallego et al.
Physiol. Genomics 2010;41:82-90.
ABSTRACT
| FULL TEXT
|